JNJ
Johnson & Johnson
Johnson & Johnson is a diversified healthcare conglomerate with a dominant political signal being its $50.3M in annual doctor payments and direct stock holdings by the executive branch.
Govt Dependence
30/100
Regulatory Density
85/100
Lobbying Intensity
20/100
Political Signal
NEUTRAL
BusinessWhat JNJ does
Johnson & Johnson operates through three segments: Pharmaceuticals (prescription drugs), MedTech (medical devices), and Consumer Health (over-the-counter products). Its revenue is derived from global sales of pharmaceuticals, medical devices, and consumer health products, with significant exposure to U.S. healthcare regulation and reimbursement.
12 months past · 3 months futureJNJ activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
240 trading days ·
27 congressional trades shown
·
1 insider buys
·
15 13F filings
·
1 past bill actions
·
16 upcoming markups
Executive Branch ConflictsJNJ held by Trump-administration officials
1 cabinet/senior official reported JNJ positions in OGE Form 278 disclosures across 4 filings.
Lifetime Government AwardsJNJ federal contracts
JNJ doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding JNJ
$11.07B
Total JNJ held by tracked 13F funds
40
Funds with JNJ positions
+39
Funds opened this quarter
Citadel Advisors
$829M
opened
2025-03-31
Citadel Advisors
$662M
opened
2025-09-30
Citadel Advisors
$651M
opened
2024-09-30
Citadel Advisors
$636M
opened
17 overlap
2025-12-31
Citadel Advisors
$572M
opened
2025-06-30
Citadel Advisors
$549M
opened
2024-12-31
Citadel Advisors
$498M
opened
2024-03-31
Bridgewater Associates
$468M
opened
2024-06-30
32 more 13F positions tracked · quarterly delta charts available in member dashboard
Politicians Trading JNJMembers of Congress with recent JNJ positions
26 politicians traded JNJ across 163 disclosed transactions totaling $3.1M (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just JNJ). 0-30 LOW · 30-60 MID · 60+ HIGH.
Ro Khanna
28 buys
15 sells
$638K
2026-04-13
LOW · 0
Kevin Hern
2 buys
2 sells
$366K
2024-12-31
LOW · 1
George Whitesides
2 sells
$350K
2025-03-24
LOW · 0
Jefferson Shreve
4 buys
2 sells
$280K
2025-05-12
LOW · 0
Gilbert Ray Cisneros
4 buys
4 sells
$162K
2025-05-30
HIGH · 61
Scott Franklin
6 buys
2 sells
$162K
2025-06-16
LOW · 0
Josh Gottheimer
12 buys
6 sells
$144K
2025-04-09
LOW · 1
Thomas H. Kean
5 sells
$138K
2026-03-26
LOW · 2
Rick W. Allen
4 sells
$130K
2024-07-16
LOW · 2
Lisa C. McClain
6 buys
6 sells
$96K
2025-10-31
LOW · 0
Lloyd Doggett
12 buys
$96K
2026-03-10
LOW · 1
Sheldon Whitehouse
2 sells
$65K
2024-07-03
LOW · 7
Pete Sessions
2 sells
$65K
2025-06-12
LOW · 0
Tommy Tuberville
2 sells
$65K
2024-10-29
LOW · 8
Sheri Biggs
2 sells
$65K
2025-03-19
LOW · 0
11 more politicians active in JNJ · full table in member dashboard
Congressional TradesWho in Congress is trading JNJ
2026-04-13
Ro Khanna
Purchase
$15,001 - $50,000
2026-03-19
John Boozman
Sale (Partial)
$1,001 - $15,000
2026-03-26
Thomas H. Kean
Sale
$1,001 - $15,000
2026-03-06
Ro Khanna
Sale
$1,001 - $15,000
2026-03-19
Richard McCormick
Sale
$1,001 - $15,000
2026-03-10
Lloyd Doggett
Purchase
$1,001 - $15,000
2026-01-23
Thomas H. Kean
Sale
$15,001 - $50,000
2025-12-18
Julie Johnson
Sale
$1,001 - $15,000
2025-12-09
Lloyd Doggett
Purchase
$1,001 - $15,000
2025-11-20
Thomas H. Kean
Sale
$15,001 - $50,000
2025-11-13
Julie Johnson
Sale
$1,001 - $15,000
2025-11-05
Richard McCormick
Purchase
$1,001 - $15,000
30+ trades on file · most recent 2026-05-13
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Open-market buys
C
Insider signal score 40/100 · 1 distinct insiders · 1 open-market buys totaling $258K in the last 180 days.
2025-11-26
MORIKIS JOHN G
BUY
1,250 sh
$258K
Bills Affecting JNJLive legislation impacting this stock
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.1875 · 119th
Medicaid Provider Screening Accountability Act
HR.1867 · 119th
To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnish
HR.1843 · 119th
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
HRES.185 · 119th
Recognizing the need of Congress to prevent, address, and treat obesity as a disease in the United States on this World Obesity Da
HRES.182 · 119th
Expressing support for the designation of March 3, 2025, as "National Triple-Negative Breast Cancer Day".
HR.1806 · 119th
Triple-Negative Breast Cancer Research and Education Act of 2025
S.793 · 119th
A bill to amend the Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019 to modify and reauthorize the
S.786 · 119th
Public Health Funding Restoration Act
HR.920 · 119th
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
Political ProfileWhere JNJ sits in Washington
[object Object]
STRUCTURAL: High regulatory density (85) from healthcare sector bills and $50.2M in annual doctor payments. Lobbying alignment is minimal ($0 reported income, 2 filings). EVIDENTIARY: Mixed congressional trading (4 buys vs 12 sales in last year). Executive branch holds JNJ stock (`get_executive_branch_exposure.by_ticker`). Single, non-clustered insider buy of $257,687 in 180 days. Net: High structural regulatory risk offset by neutral-to-mildly positive evidentiary signals from executive holdings and some congressional buys.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened scrutiny of physician payments under the Sunshine ActCMS"`get_political_influence.doctor_payments` shows $50.2M in payments from DePuy Synthes Products, Inc. in 2024."
Regulatory opportunities
-
Lobbying on Corporate Alternative Minimum Tax and R&D expensesCongress/Treasury"`Lobbying filings touching this ticker` shows focus on 'Corporate Alternative Minimum Tax Research and Development Expenses'."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
LobbyingWho's hired to advocate for JNJ
BROWNSTEIN HYATT FARBER SCHRECK, LLP OBO JOHNSON & JOHNSON finance
Member intelligence layer
Live signals + predictions for JNJ — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades JNJ
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout JNJ & political exposure
Does Johnson & Johnson (JNJ) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Johnson & Johnson. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Which Trump cabinet officials own JNJ stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in JNJ on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded JNJ stock?
805 congressional trades by 85 unique members of Congress, most recently on 2026-04-13. See the Congressional Trading panel for politician-by-politician breakdown.
What is JNJ political risk profile?
Government dependence: 30/100. Lobbying intensity: 20/100. Political signal: neutral. Donor party split: R 56% / D 44%.
How does GovGreed track JNJ political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. JNJ data is updated daily from these official federal sources.